Special Issue "Outcomes and Therapeutic Management of Bladder Cancer"
Deadline for manuscript submissions: closed (31 May 2020).
A printed edition of this Special Issue is available here.
2. Luzerner Kantonsspital, Spitalstrasse, CH-6000 Luzern, Switzerland
Interests: bladder cancer; urothelial cancer; non-muscle invasive bladder cancer; muscle invasive bladder cancer; radical cystectomy; transurethral resection of the bladder
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses for 2018 in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection is the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown improvement in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve outcomes of this potentially lethal disease.
Dr. Marco Moschini
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bladder cancer
- urothelial cancer
- non-muscle invasive bladder cancer
- muscle invasive bladder cancer
- radical cystectomy
- transurethral resection of the bladder